UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000032609
Receipt number R000037182
Scientific Title The effect of oral probiotics for healthy adults
Date of disclosure of the study information 2018/10/31
Last modified on 2020/05/19 09:28:25

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of oral probiotics for healthy adults

Acronym

The effect of oral probiotics for healthy adults

Scientific Title

The effect of oral probiotics for healthy adults

Scientific Title:Acronym

The effect of oral probiotics for healthy adults

Region

Japan


Condition

Condition

periodontal disease

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Gingiva condition of healthy adults improves by administration of lactic acid bacteria.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Bleeding of probing

Key secondary outcomes

probing depth
plaque control record
bacterial naumber
IgA


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Lactobacillus salivarius TI2711

Interventions/Control_2

placebo

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

healthy adults
PD of 4 mm or more is 10% or less, BOP is 10% or less

Key exclusion criteria

PD of 4 mm or more is 10% or more, BOP is 10% or more

Target sample size

75


Research contact person

Name of lead principal investigator

1st name Yasuhiro
Middle name
Last name Koga

Organization

Tokai University School of Medicine

Division name

Gastroenterology

Zip code

259-1193

Address

143 Shimokasuya, Isehara, Kanagawa

TEL

0463-93-1121

Email

yasuhiro@is.icc.u-tokai.ac.jp


Public contact

Name of contact person

1st name Takashi
Middle name
Last name Matsuoka

Organization

Tokai University School of Medicine

Division name

Psychiatry

Zip code

259-1193

Address

143 Shimokasuya, Isehara, Kanagawa

TEL

0463-93-1121

Homepage URL


Email

pct@k.nifty.jp


Sponsor or person

Institute

Tokai University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

KOIKE-YA Inc.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor

Hiyoshi oral Helth Clinic

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board for Clinical Research, Tokai University

Address

143 Shimokasuya, Isehara, Kanagawa

Tel

0463-93-1121

Email

tokai-rinsho@ml.tokai-u.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東海大学医学部(神奈川県)
日吉歯科診療所(山形県)


Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

29

Results

BOP was significantly different between the LS1 group and the placebo group at 12 weeks of administration. LS1 tablet confection maintained healthy gingiva for adults with healthy periodontal tissue compared to placebo tablet confection.

Results date posted

2020 Year 05 Month 19 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2018 Year 03 Month 22 Day

Date of IRB

2018 Year 01 Month 26 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2019 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 05 Month 16 Day

Last modified on

2020 Year 05 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037182


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name